Alcohol metabolizing enzymes, such as the alcohol dehydrogenases and the aldehyde dehydrogenases, regulate the levels of acetaldehyde in the blood and play an important role in the development and maintenance of alcohol addiction. Recent genome-wide systematic searches found associations between a single nucleotide polymorphism (rs1789891, risk allele: A, protective allele: C) in the alcohol dehydrogenase gene cluster and the risk of alcohol dependence. The current study investigated the effect of this single nucleotide polymorphism on alcohol consumption, craving for alcohol, relapse risk and brain gray matter volume. Alcohol-dependent patients (n = 74) and controls (n = 43) were screened, genotyped and underwent magnetic resonance imaging scanning, and relapse data were collected during 3 months following the experiment. Alcohol-dependent A allele carriers reported increased alcohol craving and higher alcohol consumption compared with the group of alcohol-dependent individuals homozygous for the C allele, which displayed craving values similar to the control group. Further, follow-up data indicated that A allele carriers relapsed earlier to heavy drinking compared with individuals with two C alleles. Analyses of gray matter volume indicated a significant genotype difference in the patient group: individuals with two C alleles had reduced gray matter volume in the left and right superior, middle and inferior temporal gyri. Findings of the current study further support the relevance of genetic variants in alcohol metabolizing enzymes to addictive behavior, brain tissue volume and relapse risk. Genotype-dependent differences in acetaldehyde formation, implicated by earlier studies, might be the biological substrate of the genotype differences.
INTRODUCTION
Alcohol is available in many cultures, and although many individuals have free access to it, only factions of these develop alcohol addiction. The susceptibility to do so depends on environmental factors as well as on the individual's genetic makeup, with a heritability of around 40 to 60 percent (Enoch & Goldman 2002) . The strongest and most robust genetic findings associated with susceptibility to develop alcohol dependence are with variants located in the genes encoding for the alcohol metabolizing enzymes alcohol dehydrogenases (ADH) and aldehyde dehydrogenases (ALDH). These enzymes jointly regulate the level of acetaldehyde: ADH oxidizes the ingested alcohol to acetaldehyde, and ALDH further oxidizes the acetaldehyde to acetate (Edenberg & Foroud 2013; Rietschel & Treutlein 2013) . Variation in the activity of these enzymes can influence the level of acetaldehyde. High acetaldehyde levels result in adverse effects such as nausea and vomiting (Quertemont 2004) . It has been suggested that increased acetaldehyde levels are protective against alcoholism (Quertemont 2004) .
Variations in genes coding for ADH and ALDH thus could have an influence on alcohol dependence. And indeed, some ADH1B and ALDH2 variants are associated with increased acetaldehyde levels and reduced risk to develop an alcohol addiction (Cederbaum 2012) . While these variants are frequent in Asian ancestry populations, they are relatively rare in populations of central European origin. A well-known example is the Arg48His polymorphism (rs1229984) in the ADH1B gene where the protective 48His allele shows increased enzyme activity and faster acetaldehyde production (Edenberg 2000 (Edenberg , 2007 . The 48His allele is the strongest known protective genetic factor in European ancestry populations. However, compared with the frequency in Asian ancestry population where it often constitutes the major allele, it has a prevalence of only around 5 percent in central European ancestry populations (Li, Zhao, & Gelernter 2011; Bierut et al. 2012; Treutlein et al. 2014) . Other recent genome-wide associations study (GWAS) confirmed the association between genetic variants in the ADH gene cluster and alcohol dependence (Gelernter et al. 2014; Schumann et al. 2016; Clarke et al. 2017) . Specifically, loci on the ADH1B (Arg48His), ADH1B/ADH1C (rs145452708) and ADH5 (rs29001570) gene cluster were identified in samples with European ancestry. In addition to ADH subtypes, enzymes such as microsomal ethanol oxidizing systems and catalase are involved in the oxidation of ethanol. The microsomal ethanol oxidizing system consists of several cytochromes (CYP), namely, CYP2E1, CYP1A2 and CYP3A4, with the first one contributing the most to the non-ADH ethanol metabolism (Quertemont 2004) . While all of the cytochromes together only account for a small part of the total ethanol metabolism, the inducibility of the cytochromes confers to the development of metabolic tolerance to ethanol. Studies found that the rare allele CYP2E1
* 5B was associated with higher CYP2E1 activation (Hayashi, Watanabe, & Kawajiri 1991) . However, no significant association with alcohol dependence could be found (Itoga, Harada, & Nomura 2001) . While catalase plays only a minor role in the total metabolization of ethanol, catalase seems to play a more prominent role in the brain, where it serves as an alternative pathway to the ADH and CYP systems (Quertemont 2004) . To date, our understanding of the catalase system is limited, and further research on this topic is needed. Moreover, genetic variants in the β-Klotho gene (rs11940694) were found to be significantly associated with alcohol consumption in humans. This effect was further investigated in animal models. Results from knockout mice indicated that as lack of β-Klotho, an obligate co-receptor for the hormone FGF21, is associated with increased alcohol consumption, pointing towards endocrine and metabolic influences on alcohol consumption beyond alcohol metabolizing enzymes (Schumann et al. 2016) . In our recent systematic GWAS of alcohol dependence in a German population, a genome-wide significant finding was obtained with a common variant located in the ADH gene cluster, between the ADH1B and ADH1C genes (Frank et al. 2012) . The minor A allele was associated with increased risk for developing an alcohol addiction, a finding that could be replicated in an independent sample from the British and Irish population (Way et al. 2015) .
The function of rs1789891 is unclear as it is located in an intragenic region and constitutes-like all other variants in the ADH genes-no expression quantitative trait locus (NCBI PheGenI at http://www.ncbi.nlm.nih. gov/gap/phegeni, accessed June 07, 2016). It is however, in complete linkage disequilibrium with a single nucleotide polymorphism (SNP), rs1693482, which is located in the ADH1C gene. This SNP results in an amino acid substitution Arg272Gln. The protective C allele of the SNP rs1789891, reported by Frank et al. (2012) , corresponded to the 272Arg variant that in vitro displays higher ethanol oxidation rate (Lee et al. 2006) , and the risk allele A corresponds to the amino acid Gln, which had previously been reported in a candidate gene study to be associated with higher alcohol intake in humans (Macgregor et al. 2009 ). As Arg272Gln, however, did not achieve genome-wide significance in our GWAS, it remains to be elucidated whether rs1789891 is a marker of this functional SNP or whether it is involved in other mechanisms. In this context, it is of interest that rs1789891 has been found associated with temperamental dimensions in patients with alcohol dependence and affective disorders (Oniszczenko et al. 2015) .
Using a reverse genetic approach, the current study investigated effects of rs1789891 on clinical parameters (e.g. craving), on relapse risk and brain volume in a sample of alcohol-dependent patients and controls. We hypothesized that alcohol-dependent A allele carriers consume more alcohol and have a higher relapse risk, probably because of less pronounced adverse effects after alcohol consumption. We further hypothesized that alcohol-dependent patients have reduced brain gray matter (GM) volume compared with controls. In addition, we sought to explore whether the variant is associated with GM volume.
EXPERIMENTAL PROCEDURES

Participants
A total of 74 alcohol-dependent patients and 43 healthy controls were recruited by newspaper advertisement (controls) and from the Department of Addictive Behavior and Addiction Medicine at the Central Institute of Mental Health (Mannheim, Germany; patients). All patients completed detoxification. Subjects of the control group responded to newspaper advertisement and were invited to the Department in order to assess eligibility for the study. In the group of alcohol-dependent patients, 30 patients were carriers of the A allele (AC and AA genotype), and 44 patients were homozygous for the protective C allele (CC genotype). The minor allele frequency (MAF) in the patient sample was 0.25. In the control group, 9 participants were carriers of the A allele, and 34 participants were homozygous for the C allele. The MAF in the control group was 0.12. Genotype distribution in the controls did not deviate from Hardy-Weinberg equilibrium (P = 0.44, Hardy-Weinberg equilibrium exact test). All participants included in the current study were drawn from middle European population. Patients had to meet all following inclusion criteria in order to take part in the study: (1) patients had to be diagnosed with alcohol dependence according to the Diagnostic Statistical Manual of Mental Disorders; (2) they had to be aged between 18 and 65 years; (3) they had to be right-handed; and (4) they had to have completed detoxification successfully (i.e. treatment-if necessary-of withdrawal symptoms with short-acting benzodiazepines or chlormethiazole had to be completed for at least 3 days; i.e. >5× elimination half-life). Patients were excluded if they met one or more of the following exclusion criteria: (1) co-morbid axis-I disorder (other than alcohol or nicotine dependence) in the last year; (2) treatment with psychotropic or anticonvulsive medications; (3) severe neurological or physiological disease; (4) positive drug screening; or (5) ineligibility for magnetic resonance imaging scanning (e.g. due to tattoos, metal implants, a pacemaker or pregnancy). Healthy control participants were only included if they (1) were aged between 18 and 65 years; (2) were righthanded; (3) did not meet the clinical diagnosis of an alcohol dependence or any other axis-I disorder; and (4) did not meet any of the exclusion criteria (see above).
Prior to taking part in the scanning procedure, all participants were screened for inclusion and exclusion criteria, and written informed consent was obtained from each participant in accordance with the Declaration of Helsinki. In addition, alcohol consumption patterns of every participant were assessed using a semi-structured interview (Form 90, Sobell et al. 1996) , and participants completed the following questionnaires: Beck Depression Inventory (Beck et al. 1961 ) and Fagerstrom Test for Nicotine Dependence (Fagerstrom & Schneider 1989) . In addition to that, the group of alcohol-dependent patients completed the Alcohol Dependence Scale (ADS, Kivlahan, Sher, & Donovan 1989) , and the Clinical Institute Withdrawal Assessment scale (Sullivan et al. 1989) was rated. Craving data were collected using a picture stimulus task, which had been validated previously by our research group (Vollstadt-Klein et al. 2012) . During the task, participants were shown 12 series of alcohol picture stimuli and 9 series of neutral picture stimuli, amounting to a total of 21 blocks. During every block, a series of five pictures (alcohol or neutral) was presented (each picture for 4 seconds), and following these, participants were asked to rate their current craving for alcohol on a visual analogue scale ranging from 0 (no craving at all) to 100 (very intense craving).
Relapse data were collected during 3 months following the scanning session for the sample of alcohol-dependent patients. Patients were contacted via telephone once a month, and a short standardized interview, which included the Alcohol Timeline Follow-back, was conducted (Sobell et al. 1996) . Information on current drinking status, relapse events and amount of alcohol consumed was collected. According to previous studies, relapse was further categorized into heavy relapse, if alcohol consumption exceeded 48 g per day for women or 60 g for men (Kiefer et al. 2011; Jorde et al. 2014) . According to earlier studies, time to first heavy relapse was used as outcome variable in the survival analyses (Kiefer et al. 2011; Bach et al. 2015) . Follow-up information was available for 67 alcohol-dependent patients (39 individuals homozygous of the C-allele and 28 A-allele carriers). Remaining patients (n = 7) took part in the study, when the followup data collection procedure was not installed yet.
The ethics committee of Heidelberg University approved the study, and all participants provided written informed consent according to the Declaration of Helsinki.
Voxel-based morphometry acquisition and data preprocessing
Voxel-based morphometry images were acquired using a 3T whole-body tomograph (MAGNETOM Trio, Siemens, Germany (Brody et al. 2004; Barnes et al. 2010) . In order to satisfy a family-wise error rate correction of PFWE < 0.05, we determined a combined voxelwise-threshold [P < 0.001] and cluster-extent-threshold [k ≥ 115] by running 10 000 Monte Carlo simulations using in the Neuroelf analysis package (www.neuroelf. net) (Bennett, Wolford, & Miller 2009) .
RESULTS
Group characteristics, alcohol consumption and craving for alcohol
Analyses showed similar values regarding age, education, gender distribution and smoking status across all groups (patients versus controls) and genotype categories (individuals homozygous for the C allele versus A allele carriers) (all P values >0.05, Table 1 ). Alcohol-dependent patients reported significantly higher daily ethanol intake in the last 90 days (M = 137.7 g, SD = 123.7) compared with the control group (M = 8.0 g, SD = 9.1, P < 0.05). In addition, there was a significant interaction between genotype and group. A allele carriers in the patient group reported significantly higher ethanol consumption (M = 186.7 g, SD = 144.3) compared with individuals homozygous for the C allele (M = 106.6 g, SD = 98.8, P < 0.05), while there was no difference between genotype groups in the control sample (P > 0.05). Results remained significant after including level of education and gender as covariates in an analysis of covariance model (F (3, 70) = 3.263, P < 0.05). Moreover, there was a significant main effect and interaction regarding craving for alcohol. Alcohol-dependent patients reported increased cue-induced craving during the cue-reactivity task (M = 10.0, SD = 15.7) compared with the control group (M = 4.4, SD = 8.6). Additionally, there was a genotype effect with A allele carriers reporting more craving for alcohol, but only in the patient group (M AA/AC = 15.1, SD AA/AC = 2.5; M CC = 6.7, SD CC = 7.3, P < 0.05).
Group and genotype differences in gray matter volume
Compared with the healthy control sample (n = 43), alcohol-dependent patients (n = 74) showed reduced GM volume in the superior, medial and inferior frontal gyri, in the postcentral and precentral gyri, in the superior and middle temporal gyri, in the hippocampus and in the parahippocampal gyrus, in the cerebellum, in the insula, in parts of the parietal and occipital gyri and in the fusiform gyrus (Table 2 and Fig. 1 ). In the patient group, individuals homozygous for the C allele had reduced GM volume compared with A allele carriers in the left superior, middle and inferior temporal gyri [t = 3.87; cluster size = 123; peak voxel (MNI) = (À38, 12, À33)] and in the right superior and middle temporal gyri [t = 3.96; cluster size = 163; peak voxel (MNI) = (38, 18, À32)] (Fig. 2) . In order to investigate, whether the observed GM differences resulted from higher ethanol consumption in patients carrying the A allele, further analyses were conducted. Significance of the results remained unchanged after controlling for differences in ethanol consumption. There were no significant genotype effects on GM volume in the control group.
Relapse to heavy drinking
Within the 3 months after the experiment, 13 of the 39 individuals homozygous for the C allele (26 non- relapsers, 67 percent) and 16 of the 28 carriers of the A allele (12 non-relapsers, 43 percent) reported a heavy relapse. Cox regression analyses revealed a significant association between genotype category (AA/AC versus CC) and time to first severe relapse (hazard ratio = 2.18, 95 percent confidence interval = 1.05-2.54, n = 67, P = 0.037) (Fig. 3 ).
DISCUSSION
The current study compared a sample of healthy controls with a sample of recently abstinent alcohol-dependent patients and investigated the effects of the SNP rs1789891 in the ADH gene cluster, which has been previously associated with the risk to develop an alcohol addiction, on craving for alcohol, alcohol consumption, brain GM volume and relapse risk.
In accordance with the results of earlier research, findings of the current study demonstrated reduced GM volume in alcohol-dependent patients relative to the healthy control sample in parts of the frontal lobe, in the postcentral and precentral gyri, in the temporal gyri, in the hippocampus and in the parahippocampal gyrus, in the cerebellum, in the insula, in parts of the parietal and occipital gyri and in the fusiform gyrus (Cardenas et al. 2007; Beck et al. 2012; Momenan et al. 2012; Le Berre et al. 2014) .
Regarding genotype differences, results of the current study indicated reduced GM volume in alcohol-dependent individuals homozygous for the C allele (protective allele) compared with carriers of the A allele (risk allele) in the left superior, middle and inferior temporal gyri and right superior and middle temporal gyri. Previous studies already demonstrated reduced GM volume in the temporal gyri of alcohol-dependent patients (Cardenas et al. 2007; Le Berre et al. 2014) . Interestingly, GM volume loss in alcohol-dependent patients was only weakly associated with measures of alcohol consumption in the past year (Cardenas et al. 2007 ). This indicates that other factors might contribute to GM loss in alcohol-dependent patients. It has already been suggested that not only alcohol per se but also alcohol metabolites, such as acetaldehyde, have toxic effects on brain tissue (Harper 2007) . This suggests that differing ethanol oxidation rates might be related to differences in GM volume. Interestingly, the C allele has been indirectly associated with an increased rate of ethanol oxidation in vitro (Lee et al. 2006; Frank et al. 2012 ). This idea is in line with the findings of the current study, demonstrating differences between alcohol-dependent patients carrying different alleles after correcting for differences in alcohol consumption. GM volume reduction in individuals homozygous for the C allele was not explained by differences in alcohol consumption. This is in line with the theorized increased acetaldehyde formation in individuals homozygous for the C allele that might be accompanied by damage to brain cells and reduced GM brain volume. Results of the current study might indicate that individuals Figure 1 Brain areas that displayed decreased gray matter volume in alcohol-dependent patients (n = 74) relative to healthy controls (n = 43) [combined voxel-wise-threshold (P < 0.001) and cluster-extent-threshold (k > 115 voxel), corresponding to PFWE < 0.05] Figure 2 In patients, individuals homozygous for the C allele (n = 44) showed reduced gray matter volume relative to A allele carriers (n = 30) in the left superior, middle and inferior temporal gyri and in the right superior and middle temporal gyri [combined voxel-wise-threshold (P < 0.001) and cluster-extentthreshold (k > 115 voxel), corresponding to PFWE < 0.05] homozygous for the C allele are more prone to the toxic effects of alcohol, probably because of differences in acetaldehyde formation. However, this interpretation is based on the assumption that ADH is considerably involved in the metabolism of alcohol in the brain. The role of ADH enzymes in the brain, once thought to be non-existent, is now evident, but still poorly understood (Heit et al. 2013) . So far, catalase and cytochrome P-450 2E1 have been thought to play the major roles in metabolizing alcohol in the brain (Deng & Deitrich 2008) . Now, it has been shown that at least the ADH1C protein is expressed in the brain of humans (The Human Protein Atlas at http://www.proteinatlas.org/ENSG00000248144-ADH1 C/tissue, accessed June 07, 2016).
Thus, further research is needed to validate the theorized association between genotype and acetaldehyde levels. Current findings did not indicate that temporal GM volume reduction is accompanied by any impairment. However, previous research found that patients that relapsed to alcohol drinking had reduced GM volume compared with patients that remained abstinent (Beck et al. 2012) . In addition, previous research on alcohol addiction and Wernicke-Korsakoff syndrome has demonstrated the importance of temporal GM volume for memory functions in alcohol-dependent patients (Visser et al. 1999; Sullivan & Pfefferbaum 2009 ). This suggests that GM volume differences might contribute to processes relevant for relapse and relapse prevention. Possible associations between ADH genotype, GM volume reduction and memory impairment should be investigated in future studies.
In line with the hypothesis that substantial amounts of alcohol consumption are needed to uncover genotype effects on GM volume, current results indicate similar GM volume across the genotype groups in the sample of healthy controls. Given low alcohol consumption, as reported by the healthy control group, genotype differences do not seem to affect GM volume. However, further research is needed to corroborate this finding.
In accordance with our hypothesis, results indicated that alcohol-dependent A allele (risk allele) carriers reported more craving for alcohol and higher alcohol consumption compared with individuals homozygous for the C allele (protective allele). This finding does also harmonize with the proposed indirect association between the C allele and increased acetaldehyde formation (Lee et al. 2006; Frank et al. 2012) . A higher ethanol oxidation rate might lead to increased intensity of side effects of alcohol consumption, such as nausea, flush and vomiting. This in turn might create a drive to avoid excessive amounts of alcohol and reduce the craving for alcohol, because of e.g. negative reinforcement, and explain the protective effect of this allele. Results of the current study harmonize with this theory, demonstrating reduced cue-induced alcohol craving in alcohol-dependent individuals homozygous for the C allele and lower reported alcohol consumption. However, no genotype effects on craving and amount of alcohol consumption could be Figure 3 Kaplan-Meier curves illustrating the heavy relapse-free survival during the 3-month follow-up for the single nucleotide polymorphism rs1789891 genotype groups in the patient sample (alcohol-dependent A allele carriers versus individuals homozygous for the C allele). Alcohol-dependent A allele carriers relapsed earlier to heavy drinking than individuals homozygous for the C allele (hazard ratio = 2.18, 95 percent confidence interval = 1.05-2.54, n = 67, P = 0.037) determined in the control group. A possible explanation might be that a history of experiencing the negative reinforcing effects of higher acetaldehyde formation is needed before any differences between genotype groups occur. In the group of healthy controls, alcohol consumption was low. This might have prevented control participants in the current sample from experiencing effects of different ethanol oxidation rates. In addition, the sample of healthy A allele carriers was quite small in the current study. Therefore, small effects might have been lost because of insufficient power.
Moreover, there was a genotype effect on time to first severe relapse. A allele carriers had an increased relapse risk compared with individuals homozygous for the protective C allele within 3 months after the experiment. This indicates that, in addition to its association to increased risk of alcohol dependence, the A allele is also associated with an increased relapse risk. The current study could not determine the biological mechanisms that lead to an increased relapse risk in carriers of the risk allele. However, the theorized association between the SNP and different levels of acetaldehyde formation, potentially resulting in more side effects (nausea, flush and vomiting) from alcohol consumption in carriers of the protective C allele, might create a drive in C allele carriers to avoid alcohol consumption. This could be a plausible pathway that should be assessed in future studies.
Multiple genetic variants in the ADH and ADH1B/1C gene clusters have been associated with alcohol addiction (Edenberg 2000 (Edenberg , 2007 Gelernter et al. 2014 ; Schumann et al. 2016 ; Clarke et al. 2017) . Prominently, multiple studies confirmed that the 48His variant of the polymorphism (rs1229984) in the ADH1B gene cluster was protective against alcohol addiction (Edenberg 2000 (Edenberg , 2007 . The current study put a focus on the SNP rs1789891 in the ADH gene cluster. Therefore, the exact contribution of this SNP to individual differences in addictive behavior in relation to other genetic variants in the ADH gene cluster remains to be determined and is beyond the scope of the current study.
LIMITATIONS
While results of the current study are in line with the hypothesized relation between ADH genotype and altered ethanol oxidation rate and acetaldehyde levels, it was beyond the scope of the current study to directly assess genotype effects on enzyme activity and acetaldehyde levels. Therefore, biological mechanisms underlying the observed genotype differences remain to be validated in future studies. In addition, some data indicated that the investigated SNP rs1789891 is in complete linkage disequilibrium with the SNP rs1693482 (D 0 = 1.0, r2 = 0.25, HapMap rel 22 CEU). Because the latter of the two was not included in the current study, it remains to be determined whether the effect is specific to the SNP rs1789891. This topic should be addressed by future research. In addition, other genetic variants in the ADH gene cluster are associated with alcohol addiction (Gelernter et al. 2014; Schumann et al. 2016; Clarke et al. 2017) . The current study focused on the investigation of a single SNP in the ADH gene cluster. The investigation of multiple SNPs within the framework of an imaging study that incorporates, due to financial and timely constraints, only a limited number of participants would have increased risk of multiple testing and reduce power to uncover individual effects. Therefore, the focus on a single SNP might be a reasonable trade-off. The small sample size with regard to other imaging genetic studies and the imbalance in absolute numbers of participants in the patient and control sample is a major limitation of the current study. This stresses the importance to replicate and validate current results in future studies. The MAF (A allele) differed between patient group and control group (MAF 25 versus 12 percent). Previous research indicated a substantial variation in genotype frequencies with regard to the SNP rs1789891. Especially for European populations, region-specific differences have been observed with reported minor allele frequencies ranging from 0.03 to 0.24. The MAF in the control group (12 percent) does resemble the MAF found for mixed European samples (https://alfred.med.yale.edu; UID: PO000020C). The high risk allele frequency in the sample of alcohol-dependent patients might hint towards differences in genetic dispositions with higher prevalence rates of alcohol dependence risk alleles in the patient sample. Regarding the education level and the proportion of male and female participants in the patient group, additional analyses of drinking data with education level and gender as covariates showed that genotype differences remain significant after controlling for both variables (analysis of covariance: F (3, 70) = 3.263, P < 0.05). Further, results of the Cox regression analyses continue to show significant associations between ADH genotype and relapse risk after including gender and education level as covariates (χ² (4) = 10.06, n = 67, P = 0.040). This supports the notion that the ADH genotype has an effect on relapse risk and ethanol consumption independent of level of education and gender.
In addition, results show similar ADS scores and number of detoxifications, as well as duration of alcohol dependence for both ADH genotype groups in the patient sample. The ADS scale was found being capable of discriminating between those with no or minimal alcohol problems and those with symptoms of excessive or abusive drinking (Kahler et al. 2003) . Taken together, this indicates that ADH genotype groups do not differ with regard to dependence severity.
While studies indicated that approximately 40-60 percent of the variance in the risk for alcohol dependence is influenced by genetic factors (Ducci & Goldman 2008) , there is substantial contribution of environmental factors. Studies have demonstrated that alcohol availability and social context are crucial factors for developing alcohol dependence. Even in populations with high prevalence of those ADH genotypes associated with high acetaldehyde formation, changes in consume patterns could be observed (World Health Organization Global status report on alcohol and health 2014, http://www.who. int, accessed July 12, 2017). For example, an increase in alcohol consumption was observed in Japan. Factors, such as social norms, have been identified as causes for this increase (Kitano et al. 1992) . These data suggest that the protective effect of genetic variants associated with higher acetaldehyde formation can be, at least partially, overcome by environmental factors. Reasons for increases in alcohol consumption might be that social pressure fuels alcohol consumption and habituation to acetaldehyde effects slowly decrease the sensitivity to alcohol-induced negative symptoms. This stresses the importance to consider social context in the investigation of factors contributing to alcohol use disorder.
SUMMARY
To summarize, current results indicated that carriers of the rs1789891 A allele experience more cue-induced alcohol craving, consume more alcohol and have an increased risk to relapse to heavy drinking compared with individuals homozygous for the C allele, who had reduced GM volume in the left and right temporal gyri. These findings further support the relevance of genotype variants in the ADH gene cluster to addictive behavior, brain tissue volume and relapse risk. While differences in acetaldehyde formation, which were implicated by earlier research, might be the biological substrate underlying current findings, further research is needed to validate this hypothesis and directly assess genotype effects on acetaldehyde blood levels in vivo.
